Which Pediatric Patients are Eligible for Ivacaftor?
Ivacaftor is approved for use in children who are at least 4 months old and have one of the specific CFTR mutations that respond to the drug. Genetic testing is essential to identify the presence of these mutations before initiating treatment.
